fda compounding semaglutide news november 2025 Hims & Hers stock falls 25% as curtails compounded GLP-1s US judge upholds FDA's removal

[1] Some individuals may be able to reduce or discontinue GLP-1 therapy if they achieve substantial lifestyle changes that improve their insulin sensitivity and glucose metabolism

And I dont know, we work with a lot of surgeons, we work with a lot of really important people, and say someones not competing, but if something goes wrong, and it comes back that you recommended or you were like, Yeah, try these injectable peptides that are not FDA regulated, and something goes wrong with the surgery or whatever they have, I just dont want that heat

Predrag Satiric of Croatia

By doing so, it may alleviate symptoms in conditions related to inflammation